Compare LITS & REKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LITS | REKR |
|---|---|---|
| Founded | 2000 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.3M | 41.7M |
| IPO Year | 2003 | 2017 |
| Metric | LITS | REKR |
|---|---|---|
| Price | $0.86 | $0.22 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 256.5K | ★ 2.6M |
| Earning Date | 11-10-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 13.81 | 4.35 |
| EPS | ★ 0.48 | N/A |
| Revenue | N/A | ★ $9,234,000.00 |
| Revenue This Year | N/A | $5.38 |
| Revenue Next Year | N/A | $16.68 |
| P/E Ratio | $1.75 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.69 | $0.21 |
| 52 Week High | $2.00 | $2.04 |
| Indicator | LITS | REKR |
|---|---|---|
| Relative Strength Index (RSI) | 34.75 | 32.59 |
| Support Level | $0.74 | N/A |
| Resistance Level | $1.08 | $0.48 |
| Average True Range (ATR) | 0.10 | 0.05 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 15.74 | 2.21 |
Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor, and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients. The company operates in the segments: Digital Asset Treasury Strategy and Development of Pharmaceutical Products.
Rekor Systems Inc is a roadway intelligence company focused on modernizing public safety, urban mobility, and transportation management through solutions. The company delivers services and solutions that collect, connect, and organize mobility data, providing real-time insights to support decision making, enhance situational awareness, enable rapid response, and support predictive analytics. The Company derives its revenues mainly from the licensing and sale of its roadway data and traffic management product and service offerings. These offerings include a mixture of data collection, implementation, engineering, customer support, and maintenance services, as well as software and hardware. The company operates in the United States and other regions.